OBJECTIVE	This open-label , non-comparative study was conducted at a single center to evaluate the effects on the endometrium of a 24-day regimen of a combined oral contraceptive containing gestodene ( GTD ) 60 microg and ethinylestradiol ( EE ) 15 microg .\